Clinigen Group PLC | Key People and Executives

Shaun Edward Chilton
Executive Director & Group Deputy CEO
Martin Abell
Chief Financial Officer & Executive Director
Anne Philomena Hyland
Non-Executive Director
Peter Vance Allen
Non-Executive Chairman
John Hartup
Independent Non-Executive Director
Ian James Nicholson
Independent Non-Executive Director
Shaun Edward Chilton
Chief Executive Officer & Executive Director
Debra Ainge
Chief Operating Officer
Martin Abell
Chief Financial Officer & Executive Director
Ivo Timmermans
Chief Medical Officer
Johann Willemse
Co-Chief Commercial Officer
Steve Glass
Co-Chief Commercial Officer
Bruce Hewett
Director-Global Commercial
David Bryant
Director-Corporate Development
Anne Philomena Hyland
Non-Executive Director
Melanie Toyne Sewell
Media Contact
Matthew Parrish
Investor Relations Contact
Jessica Archer
Global Director-Human Resources
Peter Vance Allen
Non-Executive Chairman
John Hartup
Independent Non-Executive Director
Ian James Nicholson
Independent Non-Executive Director

About Clinigen Group

View Profile
Address
Pitcairn House
Burton-on-Trent Staffordshire DE14 2WW
United Kingdom
Employees -
Website http://clinigen.co.uk
Updated 07/08/2019
Clinigen Group Plc engages in the provision of pharmaceutical products and services. It operates through the following segments: Clinigen Clinical Trial Services (CTS), Idis Managed Access (MA), Idis Global Access (GA), Clinigen Specialty Pharmaceuticals (SP), and Link Health Care. The Clinigen CTS segment sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies.